Using American diplomacy to fight NTDs

NewsGuard 100/100 Score

In a PLoS Neglected Tropical Diseases editorial, Peter Hotez of the Sabin Vaccine Institute outlines the diplomatic benefits of fighting NTDs in developing countries. He discusses why the State Department and USAID should be involved and outlines how they could work to expand NTD control.

"A global assault on NTDs both through expanded deployment of rapid impact packages and research and development for new drugs, vaccines, and diagnostics would represent a modern day Marshall Plan for the world's developing countries. Conducted jointly with the EMEs [emerging market economies] and leading OIC [Organisation of the Islamic Conference] countries, the global NTD assault would maximize civilian power in order to achieve the diplomatic and development goals of the USG," he concludes (6/28).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Nigeria first to rollout new Men5CV vaccine against meningitis